More on KMDA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $6.99 |
|
|||
| Open | $6.91 | ||||
| 52 Wk High | $6.29 | ||||
| 52 Wk Low | $3.26 | ||||
| Day High | $7.07 | ||||
| Day Low | $6.89 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 78,443 | ||||
- Benchmark Reiterates Buy Rating on Kamada Ltd. (KMDA) as $50M Sales Agreement Announced
- Kamada signs $50M plasma supply deal, sales to begin in Q4 2026
- Form 6-K KAMADA LTD For: Jul 20
- Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies
- Form 6-K KAMADA LTD For: Jul 13
- Kamada shares CYTOGAM study data from 2026 ISHLT meeting
- Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
- Form 6-K KAMADA LTD For: Jun 18
- Kamada receives FDA approval for rabies testing laboratory
- Form 6-K KAMADA LTD For: Jun 01
Entities mentioned with KMDA
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Dividend | View Related Stories »
- Show More...
